Livongo

By Laura Lovett and Dave Muoio 03:25 pm October 17, 2019
This morning chronic care management company Livongo Health inked a deal with Blue Cross and Blue Shield of Kansas City, expanding its partnership with the payer to offer its diabetes program to every fully covered Blue KC member. Livongo will also be available to Blue KC Administrative Services Only (ASO) clients.  “We are very excited to expand our partnership with Blue KC to offer their fully...
By Dave Muoio 03:50 pm October 7, 2019
Walmart’s 2020 healthcare plan for its retail associates will have some new features courtesy of partnerships with digital and remote health companies. For starters, those in the Northwest Arkansas, Orlando/Tampa and Dallas/Fort Worth areas will be provided with a “Featured Providers” tool driven by healthcare data firm Embold Health. With this, associates will receive suggestions for local,...
By Laura Lovett 02:30 pm October 7, 2019
Chronic care management company Livongo has inked a deal with the U.S. government, giving federal employees insured by the government with Type 1 or Type 2 diabetes access to the digital program.  The Livongo for Diabetes tool will be open to those insured under the Blue Cross and Blue Shield Federal Employee program, which covers roughly 5.3 million people. Users will be able to access the...

Glen Tullman (second from right) at work with the Livongo team. Photo courtesy Livongo.

By Jonah Comstock 12:38 pm September 11, 2019
Livongo isn’t the first company in the digital health space to IPO — at least, depending on how you define “digital health” it isn’t. But even if your definition is broad, Livongo stands out as one of the first companies to go public that’s really focusing on delivering healthcare, not just wellness, using consumer digital technologies. “People expect us to represent this whole new industry that...
By Laura Lovett 04:10 pm July 29, 2019
After much speculation and anticipation, chronic care management startup Livongo officially went public on Thursday. The company closed its first day 36% above its initial pricing of $28 and is currently trading for over $41 per share on NASDAQ. The company's includes more than 12 million shares of common stock. “It’s a signal to the market ... that [the industry] is ready for a consumer-first...
By Dave Muoio 12:05 pm June 28, 2019
Months after the first rumors began to swirl, chronic disease management startup Livongo Health has officially filed for an IPO on the Nasdaq Global Select Market. The company has not yet determined a price range or the number of shares going on offer. Morgan Stanley & Co., Goldman Sachs & Co. and JP Morgan Securities will serve as the lead book runners. Sources close to Livongo told...
By Dave Muoio 03:06 pm June 26, 2019
Digital chronic disease management startup Livongo is making the jump from patients’ pockets to their wrists with new integrations that will bring some of the mobile app’s alerts and features to consumer smartwatches. Starting today, certain models of Apple Watches, Fitbits and Samsung Gear wearables will surface individualized “Health Nudges” that encourage the wearer to perform certain...
By Dave Muoio 03:00 pm June 18, 2019
Home health testing platform LetsGetChecked has added three new members to its upper ranks. Dr. Robert Mordkin, whose more than 20-years of experience range from a residency at Georgetown University to a chief of urology position at Virginia Hospital Center, will serve as the company’s new chief medical officer. Richard Southern, who comes from Optum Ireland and Deloitte, is stepping into a chief...
By Dave Muoio 04:03 pm June 10, 2019
On Friday, the American Diabetes Association kicked off its annual conference in San Francisco, where academics, vendors and other stakeholders congregated to unveil new study results and major announcements related to diabetes management. And while MobiHealthNews already put together a roundup featuring an opening salvo of the show’s announcements, the past few days have seen a tidal wave of new...
By Laura Lovett 11:16 am May 23, 2019
Two months after stepping down from his role as the FDA Commissioner, Dr. Scott Gottlieb has announced he is joining the venture firm NEA, Axios first reported. Gottlieb worked for the life science investing firm prior to his time heading the regulatory agency.  “I'm delighted to rejoin the venture capital firm @NEA where I worked for a decade prior to my most recent government service; and help...